Alessandro Gronchi on Twitter: "@SprakerMDPhD @ASTRO_org @TARPSWG In addition unfortunately #STRASS didn't show any LC benefit, save for the liposarcoma subgroup. And for G1-2 only. Stay tuned... #STREXIT study results (pts treated off trial by ...
Flow chart of the STRASS RCT and the 3-year extension study - ppt download
EORTC 1809 Strass II Trial Receives Strong Support from Anticancer Fund
EORTC 1809 STRASS II Trial In Retroperitoneal Sarcoma Receives Support By The Anticancer Fund 2023 - EORTC
Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicentre, open-label, randomised, phase 3 trial - The Lancet Oncology
Preoperative radiotherapy for retroperitoneal sarcoma: Where do we go from here? | The Bulletin
PDF) Step-down strategy of spacing TNF-blocker injections for established rheumatoid arthritis in remission: Results of the multicentre non-inferiority randomised open-label controlled trial (STRASS: Spacing of TNF-blocker injections in Rheumatoid ...
Management of Primary Retroperitoneal Sarcoma (RPS) in the Adult: An Updated Consensus Approach from the Transatlantic Australasian RPS Working Group | SpringerLink
Sustainability of TNF-blocker tapering in rheumatoid arthritis over 3 years: long-term follow-up of the STRASS (Spacing of TNF-blocker injections in Rheumatoid ArthritiS Study) randomised controlled trial | RMD Open
Mudit Chowdhary, MD on Twitter: "👏🏾Congrats to the STRASS team on completing a RCT in a rare tumor like retroperitoneal #sarcoma ❌No LC benefit with #radiotherapy to surgery in RPS ❌Initial positive
STRASS 2 clinical trial receives MRFF funding - Cooper Rice-Brading Foundation
Soft tissue sarcoma (Retroperitoneal Sarcoma)
2022 July - ANZSA report | COSA
Updates in Sarcoma Benjamin Powers, MD June ppt download
Current Oncology | Free Full-Text | The Landscape of Immunotherapy for Retroperitoneal Sarcoma
Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicentre, open-label, randomised, phase 3 trial - The Lancet Oncology
Raising awareness for Sarcoma 2023 - EORTC Cancer Research Fund
Flowchart of the patients enrolled in the STRASS trial cost-utility... | Download Scientific Diagram
Sarcoma UK supports EORTC's STRASS 2 clinical trial 2023 - EORTC Cancer Research Fund
Management of Primary Retroperitoneal Sarcoma (RPS) in the Adult: A Consensus Approach From the Trans-Atlantic RPS Working Group | SpringerLink
Sustainability of TNF-blocker tapering in rheumatoid arthritis over 3 years: long-term follow-up of the STRASS (Spacing of TNF-b
Cancers | Free Full-Text | Neoadjuvant Therapy for Primary Resectable Retroperitoneal Sarcomas—Looking Forward
Soft Tissue & Bone Sarcoma Group - EORTC Cancer Research Fund
